Otic Drug Monograph Modified To Include Flammability Warning
This article was originally published in The Tan Sheet
Executive Summary
FDA is amending the final monograph for topical otic drugs to require that labeling of OTC products for drying water-clogged ears contain a flammability warning. The agency also has established mandatory directions and warnings that must appear in the labeling of ear drying aids.
You may also be interested in...
"Ear Drying Aids" Monograph Status Proposed By FDA
FDA is proposing to amend the topical otic drug products final monograph to include "ear drying aid" products with the active ingredient 95% isopropyl alcohol in a 5% anhydrous glycerin base, the agency announces in the Aug. 17 Federal Register. Such products currently are being marketed under a partial stay of a final rule classifying otic products as not generally recognized as safe and effective for OTC use.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands